Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectBlood-Brain Barrier Technologies and Global Markets
The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...
The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.
JAK and PI3K Signaling Pathway Markets
The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.
Drugs for Treating Systemic Lupus Erythematosus: Global Markets
The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.
Histone Deacetylase Inhibitors: Emerging Markets
The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.
Drugs for Treating Mental Disorders: Technologies and Global Mark...
The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
2013 Oncology Research Review
This BCC Research review provides highlights from oncology and other related market research reports published in 2013. It covers topics like uterine cancer, ovarian cancer, cervical cancer, prostrate cancer, and hematological disorders.
Medicines for Smoking Cessation: Global Markets
In 2012, the global smoking cessation medicine market had an estimated value of $2.11 billion. Estimated revenues in 2013 will be $2.12 billion. The market will observe growth after 2013 with a compound annual growth (CAGR) of 3.4% to reach $2.5 billion in 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract packaging. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract manufacturing markets. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract research. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Ubiquitin Proteasome: Global Markets for Research Tools, Diagnost...
The global market for ubiquitin proteasome research and development was estimated at nearly $2.9 billion in 2013. The market should total more than $5.5 billion by 2018, and have a five-year compound annual growth rate (CAGR) of 14.2% from 2013 to 2018.
Global Markets for Orphan Drugs - Focus on Non-Biologics
With a focus on Non-Biologics, this report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market.
Global Markets for Orphan Drugs - Focus on Biologics
With a focus on Biologics, this report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market.
Histone Methyltransferases: Global Markets for Research Tools, Di...
The global market for histone methyltransferases research and development was valued at $93 million in 2012 and is expected to reach $118 million in 2013. The market is further expected to grow at a CAGR of 18.4% and reach $275 million by 2018.
Therapies and Biomarkers for Inflammatory Bowel Disease
The market for inflammatory bowel disease therapeutics was valued at $4.8 billion in 2011 and should reach $5 billion in 2012. Total market value is expected to reach nearly $6.2 billion in 2017 after increasing at a five-year compound annual growth rate of 4.1%.
Global Markets for Treatments for Syndromes of Progressive Ataxia...
An overview of the current and future characteristics of the global market for treatments of progressive ataxia and weakness disorders, with a focus on progressive ataxia. Sales figures are estimated for the five-year period from 2012 through 2017.
Global Markets for Treatments for Syndromes of Progressive Ataxia...
An overview of the current and future characteristics of the global market for treatments of weakness disorders. Sales figures are estimated for the five-year period from 2012 through 2017.
Global Markets for Treatments of Dementia and Movement Disorders ...
With a focus on movement disorders, BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders.
Global Markets for Treatments of Dementia and Movement Disorders ...
With a focus on progressive dementia, BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders.
Global Markets for Treatments of Dementia and Movement Disorders ...
With a focus on progressive dementia with other neurological abnormalities, BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders.
Global Markets for Treatments for Syndromes of Dementia and Movem...
The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.
Choose your License
Ubiquitin Proteasome: Global Markets for Drugs, Research Tools and Diagnostics
This report provides an overview of ubiquitin proteasome, targeting therapeutics, research related products and diagnostics products. It includes the approved drugs which are available on the market and research-based products. The report covers market projections through 2028 and company profiles of the major players.
Drugs and Diagnostics for Hematological Disorders: Global Markets
This report provides an overview of the current and potential global market for hematological disorders and its treatments and testing technologies.